Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeEli Lilly and Company

      Eli Lilly and Company

      Eli Lilly Slashes Zepbound Prices for Self-Pay Patients
      Investing News

      Eli Lilly Slashes Zepbound Prices for Self-Pay Patients

      August 27, 2024
      Eli Lilly Stock Soars on GLP-1 Sales Surge and Shortage End
      Investing News

      Eli Lilly Stock Soars on GLP-1 Sales Surge and Shortage End

      August 8, 2024
      Eli Lilly Stock Surges as Novo Nordisk’s Ozempic Shows Early Kidney Study Success
      Investing News

      Eli Lilly Stock Surges as Novo Nordisk’s Ozempic Shows Early Kidney Study Success

      October 12, 2023
      Eli Lilly Shares Are Up More Than 15% So Far This Year. What’s Next?
      Investing News

      Eli Lilly Shares Are Up More Than 15% So Far This Year. What’s Next?

      August 25, 2022
      Eli Lilly’s New Products Are Essential to its Future Growth as They Aim to Release 5 New Drugs
      Investing News

      Eli Lilly’s New Products Are Essential to its Future Growth as They Aim to Release 5 New Drugs

      August 15, 2022

       

      LATEST NEWS

      • Investing News Ulta Beauty’s Q3 2025 Earnings Highlight Growth
      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025